JP Morgan Chase’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
2017
Q4
$493K Buy
2017
Q3
$367K Buy
2017
Q2
$5K Sell
2017
Q1
$52K Buy
2016
Q2
Sell
2016
Q1
$577K Sell
2015
Q4
$1.08M Sell
2015
Q3
$1.55M Sell
2015
Q2
$2.15M Buy
2015
Q1
$923K Sell
2014
Q4
$1.25M Buy
2014
Q3
$527K Buy
2014
Q2
Sell
2014
Q1
$106K Buy
2013
Q4
Sell
2013
Q3
$51K Sell
2013
Q2
$3.22M Buy